Human TGFB2/LDS4/TGF-beta2 ORF/cDNA clone-Adenovirus particle (NM_003238.3)
Cat. No.: vGMAP000588
Pre-made Human TGFB2/LDS4/TGF-beta2 Adenovirus for TGFB2 overexpression in-vitro and in-vivo. The TGFB2 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified TGFB2-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.
At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.
Go to
TGF/TGFB2/TGFB2/LDS4 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Adenovirus Grade | Adenovirus quantity |
| vGMAP000588 | Human TGFB2 Adenovirus particle | Research Grade-In vitro | 1E+10PFU (1E+10pfu/ml×1ml) |
| 5E+10PFU (1E+10pfu/ml×5ml) | |||
| 1E+11PFU (1E+10pfu/ml×10ml) | |||
| Research Grade-In vivo | 1E+11PFU (1E+11pfu/ml×1ml) | ||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMAP000588 |
| Gene Name | TGFB2 |
| Accession Number | NM_003238.3 |
| Gene ID | 7042 |
| Species | Human |
| Product Type | Adenovirus particle (overexpression) |
| Insert Length | 1245 bp |
| Gene Alias | LDS4,TGF-beta2 |
| Fluorescent Reporter | GFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGCACTACTGTGTGCTGAGCGCTTTTCTGATCCTGCATCTGGTCACGGTCGCGCTCAGCCTGTCTACCTGCAGCACACTCGATATGGACCAGTTCATGCGCAAGAGGATCGAGGCGATCCGCGGGCAGATCCTGAGCAAGCTGAAGCTCACCAGTCCCCCAGAAGACTATCCTGAGCCCGAGGAAGTCCCCCCGGAGGTGATTTCCATCTACAACAGCACCAGGGACTTGCTCCAGGAGAAGGCGAGCCGGAGGGCGGCCGCCTGCGAGCGCGAGAGGAGCGACGAAGAGTACTACGCCAAGGAGGTTTACAAAATAGACATGCCGCCCTTCTTCCCCTCCGAAAATGCCATCCCGCCCACTTTCTACAGACCCTACTTCAGAATTGTTCGATTTGACGTCTCAGCAATGGAGAAGAATGCTTCCAATTTGGTGAAAGCAGAGTTCAGAGTCTTTCGTTTGCAGAACCCAAAAGCCAGAGTGCCTGAACAACGGATTGAGCTATATCAGATTCTCAAGTCCAAAGATTTAACATCTCCAACCCAGCGCTACATCGACAGCAAAGTTGTGAAAACAAGAGCAGAAGGCGAATGGCTCTCCTTCGATGTAACTGATGCTGTTCATGAATGGCTTCACCATAAAGACAGGAACCTGGGATTTAAAATAAGCTTACACTGTCCCTGCTGCACTTTTGTACCATCTAATAATTACATCATCCCAAATAAAAGTGAAGAACTAGAAGCAAGATTTGCAGGTATTGATGGCACCTCCACATATACCAGTGGTGATCAGAAAACTATAAAGTCCACTAGGAAAAAAAACAGTGGGAAGACCCCACATCTCCTGCTAATGTTATTGCCCTCCTACAGACTTGAGTCACAACAGACCAACCGGCGGAAGAAGCGTGCTTTGGATGCGGCCTATTGCTTTAGAAATGTGCAGGATAATTGCTGCCTACGTCCACTTTACATTGATTTCAAGAGGGATCTAGGGTGGAAATGGATACACGAACCCAAAGGGTACAATGCCAACTTCTGTGCTGGAGCATGCCCGTATTTATGGAGTTCAGACACTCAGCACAGCAGGGTCCTGAGCTTATATAATACCATAAATCCAGAAGCATCTGCTTCTCCTTGCTGCGTGTCCCAAGATTTAGAACCTCTAACCATTCTCTACTACATTGGCAAAACACCCAAGATTGAACAGCTTTCTAATATGATTGTAAAGTCTTGCAAATGCAGCTAA |
| ORF Protein Sequence | MHYCVLSAFLILHLVTVALSLSTCSTLDMDQFMRKRIEAIRGQILSKLKLTSPPEDYPEPEEVPPEVISIYNSTRDLLQEKASRRAAACERERSDEEYYAKEVYKIDMPPFFPSENAIPPTFYRPYFRIVRFDVSAMEKNASNLVKAEFRVFRLQNPKARVPEQRIELYQILKSKDLTSPTQRYIDSKVVKTRAEGEWLSFDVTDAVHEWLHHKDRNLGFKISLHCPCCTFVPSNNYIIPNKSEELEARFAGIDGTSTYTSGDQKTIKSTRKKNSGKTPHLLLMLLPSYRLESQQTNRRKKRALDAAYCFRNVQDNCCLRPLYIDFKRDLGWKWIHEPKGYNANFCAGACPYLWSSDTQHSRVLSLYNTINPEASASPCCVSQDLEPLTILYYIGKTPKIEQLSNMIVKSCKCS |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Biosimilar | GMP-Bios-INN-889 | Pre-Made Lerdelimumab Biosimilar, Whole Mab, Anti-Tgfb2 Antibody: Anti-G-TSF/LDS4/TGF-beta2 therapeutic antibody |
| Target Antibody | GM-Tg-g-T14143-Ab | Anti-TGFB2/ G-TSF/ LDS4 functional antibody |
| Target Antigen | GM-Tg-g-T14143-Ag | TGFB2 protein |
| Cytokine | cks-Tg-g-GM-T14143 | transforming growth factor, beta 2 (TGFB2) protein & antibody |
| ORF Viral Vector | pGMLV000388 | Human TGFB2 Lentivirus plasmid |
| ORF Viral Vector | pGMAP000588 | Human TGFB2 Adenovirus plasmid |
| ORF Viral Vector | pGMLP-SPh-038 | Human TGFB2 Lentivirus plasmid |
| ORF Viral Vector | pGMAP-SPh-178 | Human TGFB2 Adenovirus plasmid |
| ORF Viral Vector | vGMLV000388 | Human TGFB2 Lentivirus particle |
| ORF Viral Vector | vGMAP000588 | Human TGFB2 Adenovirus particle |
| ORF Viral Vector | vGMLP-SPh-038 | Human TGFB2 Lentivirus particle |
| ORF Viral Vector | vGMAP-SPh-178 | Human TGFB2 Adenovirus particle |
Target information
| Target ID | GM-T14143 |
| Target Name | TGF/TGFB2 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
7042 |
| Gene ID |
100050377 (Equus caballus), 101093414 (Felis catus), 21808 (Mus musculus), 488596 (Canis lupus familiaris) 534069 (Bos taurus), 7042 (Homo sapiens), 707540 (Macaca mulatta), 81809 (Rattus norvegicus) |
| Gene Symbols & Synonyms | TGFB2,Tgfb2,Tgfb-2,Tgf-beta2,TGFbeta2,MGF,LDS4,G-TSF,TGF-beta2,TGF-B2 |
| Target Alternative Names | Cetermin,G-TSF,Glioblastoma-derived T-cell suppressor factor (G-TSF),LDS4,MGF,TGF,TGF-B2,TGF-beta2,TGFB2,TGFbeta2,Tgf-beta2,Tgfb-2,Tgfb2,Transforming growth factor beta-2 proprotein |
| Uniprot Accession |
P21214,P27090,P61812,Q07257
Additional SwissProt Accessions: P27090,P21214,P61812,Q07257 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Therapeutics Target, Immuno-oncology Target, INN Index, Cytokine Target |
| Disease | cancer |
| Disease from KEGG | MAPK signaling pathway, Cytokine-cytokine receptor interaction, FoxO signaling pathway, Cellular senescence, TGF-beta signaling pathway, Osteoclast differentiation, Hippo signaling pathway, AGE-RAGE signaling pathway in diabetic complications, Leishmaniasis, Chagas disease, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis B, Human T-cell leukemia virus 1 infection, Pathways in cancer, Proteoglycans in cancer, Colorectal cancer, Renal cell carcinoma, Pancreatic cancer, Chronic myeloid leukemia, Hepatocellular carcinoma, Gastric cancer, Inflammatory bowel disease, Rheumatoid arthritis, Hypertrophic cardiomyopathy, Dilated cardiomyopathy |
| Gene Ensembl | ENSECAG00000041678,ENSECAG00000051604, ENSMUSG00000039239, ENSCAFG00845028176, ENSBTAG00000005359, ENSG00000092969, ENSMMUG00000004071 |
| Target Classification | Checkpoint-Immuno Oncology, Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


